Abstract Despite enormous efforts no HIV-1 vaccine has been developed that elicits broadly neutralizing antibodies (bNAbs) to protect against infection to date. The high antigenic diversity and dense N-linked glycan armor. which covers nearly the entire HIV-1 envelope protein (Env). are major roadblocks for the development of bNAbs by vaccination. https://setartradinges.shop/product-category/trail-hat/